Replimune Group (REPL) Earnings Analysis

Replimune Group (REPL) has no confirmed upcoming earnings date. Last quarter (2026-06-29) it missed with EPS -0.76 USD vs -0.66125 USD est (-14.9%). It has beaten estimates in 0/5 recent quarters (0%). Trailing P/E -3.18.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does REPL next report earnings?

No confirmed upcoming earnings date is currently scheduled for REPL. This page updates as the calendar is published.

REPL earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-06-29-0.76 USD-0.66125 USD-14.9%Miss
2025-11-06-0.9 USD-0.87 USD-3.4%Miss
2025-08-07-0.95 USD-0.83 USD-14.5%Miss
2025-05-22-0.82 USD-0.75 USD-9.3%Miss
2025-02-12-0.79 USD-0.7 USD-12.9%Miss

Beat rate: 0/5 (0%) over reported quarters with consensus data.

REPL valuation and analyst view

Trailing P/E-3.18
Trailing EPS-3.38284 USD
Price / book6.00
Dividend yield0.00%
Market cap0.92B
Analyst consensusBuy (7 buy / 6 hold / 2 sell)
Avg price target12.5 USD

Related research pages

Frequently asked questions

When is Replimune Group (REPL)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for REPL. This page updates as the calendar is published.

Did REPL beat earnings last quarter?

In its 2026-06-29 report, REPL posted EPS of -0.76 USD versus a -0.66125 USD estimate — a miss of 14.9%.

What is REPL's earnings track record?

Over the last 5 reported quarters with consensus data, REPL beat estimates 0 times (0%).

What is REPL's current P/E ratio and EPS?

REPL trades at a trailing P/E of -3.18 on trailing EPS of -3.3828388608296063 USD.

What do analysts rate REPL?

Analyst consensus is "Buy" across 15 ratings (0 strong buy, 7 buy, 6 hold, 2 sell, 0 strong sell). Average 12-month price target: 12.5 USD.